HSD42 Performance Assessment of a Disease-Agnostic Treatment Sequencing Heuristic for Deriving Line of Therapy (LOT) in a Real-World, Rare, Multi-Tumor Cohort across Tumor Mutational Burden (TMB) Status

Autor: Bouzit, L, Burugupalli, M, Snow, T, Kerr, BT, Shankar, N, Andrus, K, Afghahi, A, Cho-Phan, C
Zdroj: In Value in Health June 2024 27(6) Supplement:S228-S228
Databáze: ScienceDirect